Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease
Clinical trial NCT03095352 · COMPLETED
Trial details
- NCT number
- NCT03095352
- Sponsor
- Laura Huppert, MD, BA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-02
- Primary completion
- 2024-11-30
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.